Neuropace, Inc. NPCE Shares Reserved for Future Issuance Under Stock Plans
Shares Reserved for Future Issuance Under Stock Plans at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s shares reserved for future issuance under stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s shares reserved for future issuance under stock plans?
- Neuropace, Inc. (NPCE) reported shares reserved for future issuance under stock plans of 8.5M in Q1 2026.
- How has Neuropace, Inc.'s shares reserved for future issuance under stock plans changed year-over-year?
- Neuropace, Inc.'s shares reserved for future issuance under stock plans increased by 6.5% year-over-year, from 8M to 8.5M.
- What is the long-term trend for Neuropace, Inc.'s shares reserved for future issuance under stock plans?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s shares reserved for future issuance under stock plans has grown at a -19.1% compound annual growth rate (CAGR), from 20.6M to 7.1M.
- What does shares reserved for future issuance under stock plans mean?
- This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.